Iatrogenic Cushing's syndrome from an adulterated glucocorticoid-containing supplement.

Authors

Hima Darapu, Sagarika Gokul

Published in

BMJ case reports. Volume 19. Issue 10. Oct 05, 2026. Epub Oct 05, 2026.

Abstract

A man in his 40s presented with rapid weight gain, fatigue and clinical signs of Cushing's syndrome, including abdominal striae and centripetal obesity. Laboratory testing revealed suppressed serum cortisol and adrenocorticotropic hormone levels. He denied prescribed glucocorticoid use but disclosed consumption of the supplement Artri King Reforzado Con Ortiga Y Omega 3 for joint pain. The U.S. Food and Drug Administration (FDA) had recalled this product for undeclared dexamethasone. The patient's symptoms started a few weeks after he discontinued the supplement and gradually improved with initiation of hydrocortisone for treatment of secondary adrenal insufficiency due to exogenous glucocorticoid use. This case illustrates the potential harm of adulterated supplements and the importance of obtaining a thorough medication and supplement history in cases of suspected iatrogenic Cushing's syndrome.

PMID:
42833837
Bibliographic data and abstract were imported from PubMed on 06 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.